| Literature DB >> 30463304 |
Yu Qian1,2,3,4, Jing Zhang5, Xianrong Zhou6,7, Ruokun Yi8,9,10, Jianfei Mu11,12, Xingyao Long13,14, Yanni Pan15,16, Xin Zhao17,18,19, Weiwei Liu20.
Abstract
Chinese pickled cabbage is a traditional fermented food that contains abundant microbes produced during the process of fermentation. In this work, an in vivo animal study was conducted to investigate the effects of a newly isolated lactic acid bacterium (Lactobacillus plantarum CQPC11, LP-CQPC11) on d-galactose-induced oxidation and aging in mice. Analysis of the serum and tissue samples of these mice using molecular biology approaches showed that LP-CQPC11 suppressed the decrease in thymus, brain, heart, liver, spleen, and kidney indices caused by oxidation and aging. Furthermore, LP-CQPC11 increased the levels of SOD (superoxide dismutase), GSH-Px (glutathione peroxidase), and GSH (glutathione), whereas it reduced the levels of NO (nitric oxide) and MDA (malondialdehyde) in the serum, liver, and spleen of oxidation and aging mouse models. Pathological observation indicated that LP-CQPC11 alleviated the damage caused by oxidation and aging on the liver and spleen of mice. qPCR analysis indicated that LP-CQPC11 effectively upregulated the expression of nNOS (neuronal nitric oxide synthase), eNOS (endothelial nitric oxide synthase), Cu/Zn-SOD (cuprozinc-superoxide dismutase), Mn-SOD (manganese superoxide dismutase), CAT (catalase), HO-1 (heme oxygenase-1), Nrf2 (nuclear factor-erythroid 2 related factor 2), γ-GCS (γ-glutamylcysteine synthetase), and NQO1 (NAD(P)H dehydrogenase [quinone] 1), but downregulated the expression of iNOS (inducible nitric oxide synthase) in the mouse liver and spleen. Western blot analysis showed that LP-CQPC11 effectively upregulated SOD1 (Cu/Zn-SOD), SOD2 (Mn-SOD), CAT, GSH1 (c-glutamylcysteine synthetase), and GSH2 (glutathione synthetase) protein expression in mouse liver and spleen tissues. These findings suggest that LP-CQPC11 can effectively prevent d-galactose-induced oxidation and aging in mice, and the effect is even better than that of the commonly used Lactobacillus delbruechii subsp. bulgaricus (LDSB) and vitamin C in the industry. Thus, LP-CQPC11 may be potentially employed as a probiotic strain.Entities:
Keywords: Lactobacillus plantarum CQPC11; aging; mice; oxidation; pickled cabbage
Mesh:
Substances:
Year: 2018 PMID: 30463304 PMCID: PMC6278364 DOI: 10.3390/molecules23113026
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1(A) Colony morphology, (B) Gram staining result, and (C) 16S rDNA agarose gel electrophoresis of PCR amplified product of Lactobacillus plantarum CQPC11. M: 2000bp DNA Ladder; 0: negative control group; 11: Lactobacillus plantarum CQPC11.
Organ index of mice in each group (n = 10).
| Group | Thymus Index | Brain Index | Cardiac Index | Liver Index | Spleen Index | Kidney Index |
|---|---|---|---|---|---|---|
| Normal | 0.25 ± 0.02 a | 1.91 ± 0.04 a | 5.02 ± 0.06 a | 38.21 ± 0.52 a | 4.12 ± 0.13 a | 12.89 ± 0.39 a |
| DGT | 0.14 ± 0.02 d | 1.17 ± 0.07 d | 4.12 ± 0.05 e | 30.32 ± 1.32 e | 2.67 ± 0.28 e | 9.22 ± 0.27 e |
| DGT + LDSB | 0.18 ± 0.02 c | 1.48 ± 0.06 c | 4.35 ± 0.08 d | 33.15 ± 0.46 d | 3.28 ± 0.12 d | 10.03 ± 0.26 d |
| DGT + LP-CQPC11 | 0.22 ± 0.01 b | 1.79 ± 0.06 b | 4.81 ± 0.07 b | 35.73 ± 0.67 b | 3.77 ± 0.15 b | 12.11 ± 0.20 b |
| DGT + Vc | 0.19 ± 0.02 c | 1.54 ± 0.07 c | 4.62 ± 0.07 c | 34.39 ± 0.47 c | 3.49 ± 0.11 c | 11.46 ± 0.25 c |
Values presented are the mean ± standard deviation (n = 10/group). a–d In the same column, the different letters mean that there are significant differences (p < 0.05) between every two groups, and the same letters mean that there is no significant difference (p > 0.05) between every two groups according to Duncan’s multiple range test. DGT: mice treated with d-galactose; DGT + LDSB: mice treated with d-galactose and Lactobacillus delbruechii subsp. bulgaricus (1.0 × 109 CFU/kg); DGT + LP-CQPC11: mice treated with d-galactose and Lactobacillus plantarum CQPC11 (1.0 × 109 CFU/kg); DGT + Vc: mice treated with d-galactose and vitamin C (200 mg/kg).
The levels of NO, SOD, GSH-Px, GSH, and MDA in serum of mice (n = 10).
| Group | NO (μmol/L) | SOD (U/mL) | GSH-Px (U/mL) | GSH (mg/L) | MDA (nmol/mL) |
|---|---|---|---|---|---|
| Normal | 18.79 ± 0.45 e | 275.36 ± 8.71 a | 182.36 ± 7.87 a | 37.33 ± 0.52 a | 5.57 ± 0.35 e |
| DGT | 63.69 ± 1.12 a | 97.63 ± 8.16 e | 103.55 ± 6.89 e | 14.02 ± 1.13 e | 29.35 ± 1.03 a |
| DGT + LDSB | 42.72 ± 1.02 b | 203.56 ± 9.71 d | 119.71 ± 4.38 d | 18.33 ± 0.55 d | 20.45 ± 0.59 b |
| DGT + LP-CQPC11 | 30.55 ± 0.67 d | 147.83 ± 7.89 b | 152.03 ± 5.88 b | 29.42 ± 0.63 b | 10.32 ± 0.38 d |
| DGT + Vc | 38.32 ± 0.66 c | 178.36 ± 6.25 c | 133.20 ± 6.34 c | 23.57 ± 0.61 c | 16.74 ± 0.68 c |
Values presented are the mean ± standard deviation (n = 10/group). a–e In the same column, the different letters mean that there are significant differences (p < 0.05) between every two groups according to Duncan’s multiple range test. DGT: mice treated with d-galactose; DGT + LDSB: mice treated with d-galactose and Lactobacillus delbruechii subsp. bulgaricus (1.0 × 109 CFU/kg); DGT + LP-CQPC11: mice treated with d-galactose and Lactobacillus plantarum CQPC11 (1.0 × 109 CFU/kg); DGT + Vc: mice treated with d-galactose and vitamin C (200 mg/kg).
The levels of NO, SOD, GSH-Px, GSH, and MDA in liver of mice (n = 10).
| Group | NO (μmol/gprot) | SOD (U/mgprot) | GSH-Px (U/mgprot) | GSH (mg/gprot) | MDA (nmol/mgprot) |
|---|---|---|---|---|---|
| Normal | 3.21 ± 0.15 e | 95.18 ± 5.32 a | 163.21 ± 7.91 a | 8.32 ± 0.28 a | 2.11 ± 0.19 e |
| DGT | 9.45 ± 0.41 a | 31.02 ± 2.65 e | 91.03 ± 4.53 e | 2.65 ± 0.29 e | 9.39 ± 0.42 a |
| DGT + LDSB | 7.16 ± 0.33 b | 48.63 ± 4.61 d | 113.25 ± 5.33 d | 4.32 ± 0.25 d | 6.41 ± 0.33 b |
| DGT + LP-CQPC11 | 4.85 ± 0.12 d | 74.36 ± 5.01 b | 140.73 ± 3.25 b | 6.12 ± 0.22 b | 3.89 ± 0.21 d |
| DGT + Vc | 5.74 ± 0.20 c | 60.87 ± 4.33 c | 127.18 ± 4.25 c | 5.39 ± 0.28 c | 4.77 ± 0.18 c |
Values presented are the mean ± standard deviation (n = 10/group). a–e In the same column, the different letters mean that there are significant differences (p < 0.05) between every two groups according to Duncan’s multiple range test. DGT: mice treated with d-galactose; DGT + LDSB: mice treated with d-galactose and Lactobacillus delbruechii subsp. bulgaricus (1.0 × 109 CFU/kg); DGT + LP-CQPC11: mice treated with d-galactose and Lactobacillus plantarum CQPC11 (1.0 × 109 CFU/kg); DGT + Vc: mice treated with d-galactose and vitamin C (200 mg/kg).
The levels of NO, SOD, GSH-Px, GSH, and MDA in spleen of mice (n = 10).
| Group | NO (μmol/gprot) | SOD (U/mgprot) | GSH-Px (U/mgprot) | GSH (mg/gprot) | MDA (nmol/mgprot) |
|---|---|---|---|---|---|
| Normal | 1.49 ± 0.15 e | 70.87 ± 3.26 a | 115.36 ± 4.22 a | 5.89 ± 0.18 a | 1.03 ± 0.06 e |
| DGT | 7.41 ± 0.28 a | 22.36 ± 4.12 e | 44.31 ± 3.55 e | 1.52 ± 0.23 e | 4.24 ± 0.16 a |
| DGT + LDSB | 5.88 ± 0.24 c | 45.97 ± 3.87 d | 60.12 ± 2.88 d | 2.74 ± 0.21 d | 3.11 ± 0.15 b |
| DGT + LP-CQPC11 | 2.28 ± 0.14 d | 61.25 ± 2.02 b | 87.71 ± 3.91 b | 4.12 ± 0.24 b | 1.62 ± 0.10 d |
| DGT + Vc | 3.31 ± 0.20 c | 51.88 ± 2.31 c | 69.78 ± 3.02 c | 3.65 ± 0.22 c | 2.41 ± 0.11 c |
Values presented are the mean ± standard deviation (n = 10/group). a–e In the same column, the different letters mean that there are significant differences (p < 0.05) between every two groups according to Duncan’s multiple range test. DGT: mice treated with d-galactose; DGT + LDSB: mice treated with d-galactose and Lactobacillus delbruechii subsp. bulgaricus (1.0 × 109 CFU/kg); DGT + LP-CQPC11: mice treated with d-galactose and Lactobacillus plantarum CQPC11 (1.0 × 109 CFU/kg); DGT + Vc: mice treated with d-galactose and vitamin C (200 mg/kg).
Figure 2H&E pathological observation of liver in mice. Magnification 100× DGT: mice treated with d-galactose; DGT + LDSB: mice treated with d-galactose and Lactobacillus delbruechii subsp. bulgaricus (1.0 × 109 CFU/kg); DGT + LP-CQPC11: mice treated with d-galactose and Lactobacillus plantarum CQPC11 (1.0 × 109 CFU/kg); DGT + Vc: mice treated with d-galactose and vitamin C (200 mg/kg).
Figure 3H&E pathological observation of spleen in mice. Magnification 100×. DGT: mice treated with d-galactose; DGT + LDSB: mice treated with d-galactose and Lactobacillus delbruechii subsp. bulgaricus (1.0 × 109 CFU/kg); DGT + LP-CQPC11: mice treated with d-galactose and Lactobacillus plantarum CQPC11 (1.0 × 109 CFU/kg); DGT + Vc: mice treated with d-galactose and vitamin C (200 mg/kg).
Figure 4The mRNA expression in liver of mice. a–e The different letters mean that there are significant differences (p < 0.05) between every two groups according to Duncan’s multiple range test. DGT: mice treated with d-galactose; DGT + LDSB: mice treated with d-galactose and Lactobacillus delbruechii subsp. bulgaricus (1.0 × 109 CFU/kg); DGT + LP-CQPC11: mice treated with d-galactose and Lactobacillus plantarum CQPC11 (1.0 × 109 CFU/kg); DGT + Vc: mice treated with d-galactose and vitamin C (200 mg/kg).
Figure 5The mRNA expression in spleen of mice. a–e The different letters mean that there are significant differences (p < 0.05) between every two groups according to Duncan’s multiple range test. DGT: mice treated with d-galactose; DGT + LDSB: mice treated with d-galactose and Lactobacillus delbruechii subsp. bulgaricus (1.0 × 109 CFU/kg); DGT + LP-CQPC11: mice treated with d-galactose and Lactobacillus plantarum CQPC11 (1.0 × 109 CFU/kg); DGT + Vc: mice treated with d-galactose and vitamin C (200 mg/kg).
Figure 6The protein expression in liver of mice. a–e The different letters mean that there are significant differences (p < 0.05) between every two groups according to Duncan’s multiple range test. DGT: mice treated with d-galactose; DGT + LDSB: mice treated with d-galactose and Lactobacillus delbruechii subsp. bulgaricus (1.0 × 109 CFU/kg); DGT + LP-CQPC11: mice treated with d-galactose and Lactobacillus plantarum CQPC11 (1.0 × 109 CFU/kg); DGT + Vc: mice treated with d-galactose and vitamin C (200 mg/kg).
Figure 7The protein expression in spleen of mice. a–e The different letters mean that there are significant differences (p < 0.05) between every two groups according to Duncan’s multiple range test. DGT: mice treated with d-galactose; DGT + LDSB: mice treated with d-galactose and Lactobacillus delbruechii subsp. bulgaricus (1.0 × 109 CFU/kg); DGT + LP-CQPC11: mice treated with d-galactose and Lactobacillus plantarum CQPC11 (1.0 × 109 CFU/kg); DGT + Vc: mice treated with d-galactose and vitamin C (200 mg/kg).
Sequences of primers used in this study.
| Gene Name | Sequence |
|---|---|
|
| Forward: 5′-ACGGCAAACTGCACAAAGC-3′ |
| Reverse: 5′-CGTTCTCTGAATACGGGTTGTTG-3′ | |
|
| Forward: 5′-TCAGCCATCACAGTGTTCCC-3′ |
| Reverse: 5′-ATAGCCCGCATAGCGTATCAG-3′ | |
|
| Forward: 5′-GTTCTCAGCCCAACAATACAAGA-3′ |
| Reverse: 5′-GTGGACGGGTCGATGTCAC-3′ | |
|
| Forward: 5′-AACCAGTTGTGTTGTCAGGAC-3′ |
| Reverse: 5′-CCACCATGTTTCTTAGAGTGAGG-3′ | |
|
| Forward: 5′-CAGACCTGCCTTACGACTATGG-3′ |
| Reverse: 5′-CTCGGTGGCGTTGAGATTGTT-3′ | |
|
| Forward: 5′- GGAGGCGGGAACCCAATAG -3′ |
| Reverse: 5′-GTGTGCCATCTCGTCAGTGAA-3′ | |
|
| Forward: 5′-ACAGATGGCGTCACTTCG-3′ |
| Reverse: 5′-TGAGGACCCACTGGAGGA-3′ | |
|
| Forward: 5′-CAGTGCTCCTATGCGTGAA-3′ |
| Reverse: 5′-GCGGCTTGAATGTTTGTC-3′ | |
|
| Forward: 5′-GCACATCTACCACGCAGTCA-3′ |
| Reverse: 5′-CAGAGTCTCAAGAACATCGCC-3′ | |
|
| Forward: 5′-CTTTAGGGTCGTCTTGGC-3′ |
| Reverse: 5′-CAATCAGGGCTCTTCTCG-3′ | |
|
| Forward: 5′-AGGTCGGTGTGAACGGATTTG-3′ |
| Reverse: 5′-GGGGTCGTTGATGGCAACA-3′ |
nNOS: neuronal nitric oxide synthase; eNOS: endothelial nitric oxide synthase; iNOS: inducible nitric oxide synthase; Cu/Zn-SOD: cuprozinc-superoxide dismutase; Mn-SOD: manganese superoxide dismutase; CAT: catalase; HO-1: heme oxygenase-1; Nrf2: nuclear factor-erythroid 2 related factor 2; γ-GCS: γ-glutamylcysteine synthetase; NQO1: NAD(P)H dehydrogenase [quinone] 1; GAPDH: glyceraldehyde-3-phosphate dehydrogenase.